Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Waaser steps up as CEO of Systagenix

This article was originally published in Clinica

Executive Summary

Systagenix Wound Management (Gatwick, UK) has appointed Ernest Waaser CEO. Mr Waaser has led a number of large, multinational healthcare companies; he was most recently president of Teleflex Medical and prior to that, he was president and CEO of Hill-Rom. Mr Waaser replaces Steve Atkinson, who has been at the helm since Systagenix was created in December 2008 following the management buy-out of Ethicon's professional wound care business. The transaction was led by One Equity Partners. On leaving Systagenix, Mr Atkinson will continue to work with One Equity Partners as a consultant and advisor on medical device investments.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT097402

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel